Hoppe CC, Inati AC, Brown C, et al. Initial Results from a Cohort in a Phase 2a Study (GBT440-007) Evaluating Adolescents with Sickle Cell Disease Treated with Multiple Doses of GBT440, a HbS Polymerization Inhibitor. ASH 59th Annual Meeting & Exhibition, abstract 689.
Meer trombotische complicaties dan gedacht bij coronapatiënten op IC
mei 2020 | Benigne hematologie, Pneumonie, Virale infecties